BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 155127)

  • 21. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
    Mikami A; Kohno M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
    Kluft C; Cooper P; Jie AF; Lowe GD; Forbes CD; Blamey SL; van de Putte LB
    Haemostasis; 1985; 15(2):144-50. PubMed ID: 3874124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
    Moroz LA; Gilmore NJ
    Blood; 1976 Oct; 48(4):531-45. PubMed ID: 134751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema.
    Oltvai ZN; Wong EC; Atkinson JP; Tung KS
    Lab Invest; 1991 Oct; 65(4):381-8. PubMed ID: 1921329
    [No Abstract]   [Full Text] [Related]  

  • 25. [Episodes of angioedema in children with C1 esterase inhibitor deficiency].
    Hemels MA; Geelen SP; Hoekstra MO; Meijer Y
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):631-4. PubMed ID: 16610507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum inhibitors in fibrinolysis.
    Gallimore MJ
    Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study by means of enzymatic and immunochemical determination of Cl esterase inhibitor in 59 patients with hereditary angioneurotic edema].
    Agostoni A; Marasini B; Cicardi M; Martignoni G; Brenna O
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):22-8. PubMed ID: 861073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunochemical studies on proteinase inhibitor of co-precipitation after euglobulin fraction of plasma (author's transl)].
    Miyatani K
    Rinsho Byori; 1979; 27(1):57-9. PubMed ID: 311865
    [No Abstract]   [Full Text] [Related]  

  • 30. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction between heparin and plasmin on amidolysis.
    Kohn S; Sakurama S; Morioka T; Ito Y; Yasukouchi T; Nakagawa S
    Thromb Haemost; 1979 Dec; 42(4):1261-75. PubMed ID: 161669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary angioedema].
    Sabbah A; Marsollier I; Trouillard V
    Allerg Immunol (Paris); 1989 Oct; 21(8):297-300. PubMed ID: 2803509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.
    Wallace EM; Perkins SJ; Sim RB; Willis AC; Feighery C; Jackson J
    Mol Med; 1997 Jun; 3(6):385-96. PubMed ID: 9234243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial occurrence of C1-inhibitor deficiency and the effect of treatment.
    MadaliƄski K; Sabbouh K; Imielska D; Chorazykiewicz M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):669-74. PubMed ID: 2487375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular interaction between synthetic spirobutenolides and C1 esterase normal inhibitor].
    Bador P; Ollier-Hartmann MP; Paris J; Hartmann L
    C R Acad Sci III; 1986; 303(3):55-8. PubMed ID: 3093005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor.
    Stief TW; Aab A; Heimburger N
    Thromb Res; 1988 Mar; 49(6):581-9. PubMed ID: 2455361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease inhibitors and human plasmin: interaction in a whole plasma system.
    Highsmith RF; Weirich CJ; Burnett CJ
    Biochem Biophys Res Commun; 1977 Dec; 79(3):648-56. PubMed ID: 145863
    [No Abstract]   [Full Text] [Related]  

  • 40. New-variant hereditary angioedema in three brothers with normal C1 esterase inhibitor level and function.
    Gupta S; Yu F; Klaustermeyer WB
    Allergy; 2004 May; 59(5):557-8. PubMed ID: 15080842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.